Japanese Pharma Company Takeda Expects Limited Exposure To US-China Tariffs

benzinga.com/general/biotech/25/05/45289103/japanese-pharma-company-takeda-expects-limited-exposure-to-us-china-tariffs

Takeda Pharmaceutical Company Limited (NYSE:TAK) reported a fiscal year 2024 net profit of 107.9 billion yen (around $709.86 million), down 25.1% year over year.
Core net profit increased 2.5% (down 3.4% at constant currency) to 775.6 billion yen.
Takeda CEO Christophe Weber said, "Takeda…

This story appeared on benzinga.com, 2025-05-08 14:32:03.
The Entire Business World on a Single Page. Free to Use →